30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Translate Bio Inc (TBIO)

Track

Stock chart
Ticker: TBIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Renaud Ronald C JR
Chief Executive Officer
3 sales — total 36,254,014 USD
Sale 14 Sep 2021
Value US$2,614,885.76 | Price 428.26 | Shares 43,492
Sale 14 Sep 2021
Value US$2,835,434.58 | Price 391.90 | Shares 72,696
Sale 14 Sep 2021
Value US$19,122,778.00 | Price 38.00 | Shares 503,231
Sale 14 Sep 2021
Value US$312,647.98 | Price 410.96 | Shares 22,857
Planned sale 14 Sep 2021
Value US$78,092,394.00 | Price 38.00 | Shares 2,055,063
Buy 14 Sep 2021
Value US$779,607,430.00 | Price 38.00 | Shares 20,515,985
Buy 14 Sep 2021
Value US$1,955,769,256.00 | Price 38.00 | Shares 51,467,612
Sale 14 Sep 2021
Value US$2,729,654.00 | Price 38.00 | Shares 71,833
Planned sale 22 Dec 2020
Value US$69,882.75 | Price 25.88 | Shares 2,700
Planned sale 22 Dec 2020
Value US$1,999,987.32 | Price 25.04 | Shares 79,865
Planned sale 21 Dec 2020
Value US$1,441,928.07 | Price 25.50 | Shares 56,536
Sale 27 Aug 2020
Value US$145,217.07 | Price 14.38 | Shares 10,097
Sale 26 Aug 2020
Value US$656,745.60 | Price 14.80 | Shares 44,381
Sale 25 Aug 2020
Value US$516,160.32 | Price 15.00 | Shares 34,410
Sale 3 Jun 2020
Value US$791,698.50 | Price 19.75 | Shares 40,086
Sale 2 Jun 2020
Value US$100,220.12 | Price 20.02 | Shares 5,006
Sale 2 Jun 2020
Value US$1,982,682.75 | Price 19.75 | Shares 100,389
Sale 1 Jun 2020
Value US$28,742.00 | Price 20.53 | Shares 1,400
Sale 1 Jun 2020
Value US$2,125,379.20 | Price 19.85 | Shares 107,072
Buy 2 Jul 2018
Value US$3,499,990.00 | Price 13.00 | Shares 269,230
Buy 2 Jul 2018
Value US$325,000.00 | Price 13.00 | Shares 25,000
Buy 2 Jul 2018
Value US$3,499,990.00 | Price 13.00 | Shares 269,230
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
43,492 +49.9%
428.26
US$2,614,886 		43,492 +49.9% 428.26 US$2,614,886
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
72,696 -20.6%
391.90
US$2,835,435 		72,696 -20.6% 391.90 US$2,835,435
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
91,599 +19.0%
345.95
US$4,093,125 		91,599 +19.0% 345.95 US$4,093,125
2021-09-14 2021-09-14 S Sale
3.0
Hughes Owen
Non-Executive Director
29,860 -100.0%
38.00
US$1,134,680 		29,860 -100.0% 38.00 US$1,134,680
2021-09-14 2021-09-14 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
2,055,063 -100.0%
38.00
US$78,092,394 		2,055,063 -100.0% 38.00 US$78,092,394
2021-09-14 2021-09-14 B Purchase
2.4
Sanofi
Large shareholder
20,515,985 +37.2%
38.00
US$779,607,430 		20,515,985 +37.2% 38.00 US$779,607,430
2021-09-14 2021-09-14 B Purchase
2.4
Sanofi
Large shareholder
51,467,612 +1396.9%
38.00
US$1,955,769,256 		51,467,612 +1396.9% 38.00 US$1,955,769,256
2021-09-14 2021-09-14 S Sale
3.0
Burgess Paul D.

Chief Operating Officer, CLO

Officer
71,833 -100.0%
38.00
US$2,729,654 		71,833 -100.0% 38.00 US$2,729,654
2020-12-23 2020-12-22 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
2,700 -5.8%
25.88
US$69,883 		2,700 -5.8% 25.88 US$69,883
2020-12-23 2020-12-22 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
79,865 -63.1%
25.04
US$1,999,987 		79,865 -63.1% 25.04 US$1,999,987
2020-12-23 2020-12-21 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
56,536 -30.9%
25.50
US$1,441,928 		56,536 -30.9% 25.50 US$1,441,928
2020-08-27 2020-08-27 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
10,097 -0.3%
14.38
US$145,217 		10,097 -0.3% 14.38 US$145,217
2020-08-27 2020-08-26 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
44,381 -1.1%
14.80
US$656,746 		44,381 -1.1% 14.80 US$656,746
2020-08-27 2020-08-25 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
34,410 -0.9%
15.00
US$516,160 		34,410 -0.9% 15.00 US$516,160
2020-06-05 2020-06-03 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
40,086 -0.6%
19.75
US$791,698 		40,086 -0.6% 19.75 US$791,698
2020-06-03 2020-06-02 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
5,006 -0.1%
20.02
US$100,220 		5,006 -0.1% 20.02 US$100,220
2020-06-03 2020-06-02 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
100,389 -1.4%
19.75
US$1,982,683 		100,389 -1.4% 19.75 US$1,982,683
2020-06-03 2020-06-01 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
1,400 -0.0%
20.53
US$28,742 		1,400 -0.0% 20.53 US$28,742
2020-06-03 2020-06-01 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
107,072 -1.5%
19.85
US$2,125,379 		107,072 -1.5% 19.85 US$2,125,379
2018-07-05 2018-07-02 B Purchase Gallagher Brian M. Jr. Non-Executive Director
269,230 +7.9%
13.00
US$3,499,990 		269,230 +7.9% 13.00 US$3,499,990
2018-07-03 2018-07-02 B Purchase MRL Ventures Fund LLC Large shareholder
25,000 +1.4%
13.00
US$325,000 		25,000 +1.4% 13.00 US$325,000
2018-07-03 2018-07-02 B Purchase GLAXOSMITHKLINE PLC Large shareholder
269,230 +7.9%
13.00
US$3,499,990 		269,230 +7.9% 13.00 US$3,499,990
Explore more

More insider trading research around Translate Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America